The place of myeloid growth factors in the treatment of hairy-cell leukaemia.
A patient with hairy-cell leukaemia was treated with granulocyte colony stimulating factor lenograstim (Granocyte) 300 micrograms daily by subcutaneous injections. His pre-existing neutropenia remitted and the therapy was continued for a total of 4 months. When the therapy was discontinued the neutropenia returned. There was no evidence that the growth factor itself had any disease modifying activity.
Christopoulos
C
C
Department of Internal Medicine, Agia Olga General Hospital, Athens, Greece.
Fortis
A
A
Nikzas
D
D
Anevlavis
E
E
D000368:Aged; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000188:drug therapy; D012008:Recurrence
D016179:Granulocyte Colony-Stimulating Factor